Myeloma specialist Dr. Yan Leyfman from Icahn School of Medicine at Mount Sinai South Nassau in collaboration with HealthTree, shared their findings at the ASCO 2024 conference in June.
Dietary supplements are widely used by cancer patients in the United States, with about 70% of patients incorporating them into their routines. This is especially true for patients with plasma cell disorders who show a strong interest in supplements.
In the poster presentation, Dr. Leyfman highlighted that the survey made through HealthTree Cure Hub played an important role in understanding patients’ perceptions and their use of supplements after receiving a myeloma diagnosis.
This survey highlights a significant interest in supplement use among patients with plasma cell disorders and a clear need for more research. An overwhelming 91% of patients expressed interest in more research on the risks and benefits of supplement use.
The results show that many patients increased or started using supplements after being diagnosed, often relying on their oncologist's advice. Most of them obtained information from their attending physician and medical media. Patients used supplements mainly for immune support, to prevent nutritional deficiencies, and to stop the cancer from progressing.
This survey highlights the importance of patient participation and self-advocacy in research. It promotes patients' real needs and preferences and helps plan better ways to support them. Survey studies like this are key to understanding how supplements can be safely and effectively used in cancer care.
Patients are encouraged to discuss any supplement use with their healthcare providers to ensure safe and coordinated care.
You can also actively participate in research by joining the HealthTree Cure Hub community!
If you are interested in participating in or finding a clinical trial, keeping track of your myeloma, or answering surveys that address patients' research needs, you can create a free account and safely connect your records!
Myeloma specialist Dr. Yan Leyfman from Icahn School of Medicine at Mount Sinai South Nassau in collaboration with HealthTree, shared their findings at the ASCO 2024 conference in June.
Dietary supplements are widely used by cancer patients in the United States, with about 70% of patients incorporating them into their routines. This is especially true for patients with plasma cell disorders who show a strong interest in supplements.
In the poster presentation, Dr. Leyfman highlighted that the survey made through HealthTree Cure Hub played an important role in understanding patients’ perceptions and their use of supplements after receiving a myeloma diagnosis.
This survey highlights a significant interest in supplement use among patients with plasma cell disorders and a clear need for more research. An overwhelming 91% of patients expressed interest in more research on the risks and benefits of supplement use.
The results show that many patients increased or started using supplements after being diagnosed, often relying on their oncologist's advice. Most of them obtained information from their attending physician and medical media. Patients used supplements mainly for immune support, to prevent nutritional deficiencies, and to stop the cancer from progressing.
This survey highlights the importance of patient participation and self-advocacy in research. It promotes patients' real needs and preferences and helps plan better ways to support them. Survey studies like this are key to understanding how supplements can be safely and effectively used in cancer care.
Patients are encouraged to discuss any supplement use with their healthcare providers to ensure safe and coordinated care.
You can also actively participate in research by joining the HealthTree Cure Hub community!
If you are interested in participating in or finding a clinical trial, keeping track of your myeloma, or answering surveys that address patients' research needs, you can create a free account and safely connect your records!
about the author
Jimena Vicencio
Jimena is an International Medical Graduate and a member of the HealthTree Writing team. She has a passion for languages and is currently learning Japanese. In her free time, she loves playing with her cats. Jimena is also pursuing a bachelor's degree in journalism.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.